Metepa
Подписчиков: 0, рейтинг: 0
|
| |
| Names | |
|---|---|
|
IUPAC name
1-[Bis(2-methyl-1-aziridinyl)phosphoryl]-2-methylaziridine
| |
|
Preferred IUPAC name
1,1′,1″-Phosphoryltris(2-methylaziridine) | |
| Other names
Methaphoxide
Metapoxide Methyl aphoxide METEPA Trimethylaziridinylphosphine oxide MAPO Tris(1,2-propylene)phosphoramide Tris(2-methyl-1-aziridinyl)phosphine oxide | |
| Identifiers | |
|
|
|
3D model (JSmol)
|
|
| ChemSpider |
|
| ECHA InfoCard | 100.000.296 |
| KEGG |
|
|
PubChem CID
|
|
| UNII | |
|
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C9H18N3OP | |
| Molar mass | 215.237 g·mol−1 |
| Appearance | Colorless liquid |
| Boiling point | 90 to 92 °C (194 to 198 °F; 363 to 365 K) (0.15-0.3 mmHg) |
| Hazards | |
| Lethal dose or concentration (LD, LC): | |
|
LD50 (median dose)
|
136 mg/kg (male rat, oral) 213 mg/kg (female rat, oral) |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Metepa is a chemosterilant, with the capability to restrict ovarian development. Metepa can also result in carcinogenesis, in particular the formation of teratomas. It is sometimes used as a Rocket propellant.